FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Sai Life Sciences IPO and Vishal Mega Mart IPO.
Sai Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Vishal Mega Mart IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Sai Life Sciences IPO | Vishal Mega Mart IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Iifl Securities Ltd Jefferies India Private Limited Morgan Stanley India Company Pvt Ltd |
Kotak Mahindra Capital Company Limited ICICI Securities Limited Intensive Fiscal Services Private Limited Jefferies India Private Limited J.P. Morgan India Private Limited Morgan Stanley India Company Pvt Ltd |
Registrar | Kfin Technologies Limited | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL |
The total issue size of Sai Life Sciences IPO is up to ₹3,042.62 Cr whereas the issue size of the Vishal Mega Mart IPO is up to ₹8,000.00 Cr. The final issue price of Sai Life Sciences IPO is and of Vishal Mega Mart IPO is .
Sai Life Sciences IPO | Vishal Mega Mart IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹522.00 per share | ₹74.00 per share |
Issue Price (Upper) | ₹549.00 per share | ₹78.00 per share |
Issue Price (Final) | ||
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 27 shares | 190 shares |
Fresh Issue Size | 1,73,04,189 shares | |
Fresh Issue Size (Amount) | up to ₹950.00 Cr | |
OFS Issue Size | 3,81,16,934 shares | 1,02,56,41,025 shares |
OFS Issue Size (Amount) | up to ₹2,092.62 Cr | up to ₹8,000.00 Cr |
Issue Size Total | 5,54,21,123 shares | 1,02,56,41,025 shares |
Issue Size Total (Amount) | up to ₹3,042.62 Cr | up to ₹8,000.00 Cr |
Sai Life Sciences IPO opens on Dec 11, 2024, while Vishal Mega Mart IPO opens on Dec 11, 2024. The closing date of Sai Life Sciences IPO and Vishal Mega Mart IPO is Dec 13, 2024, and Dec 13, 2024, respectively.
Sai Life Sciences IPO | Vishal Mega Mart IPO | |
---|---|---|
Anchor Bid Date | Dec 10, 2024 | Dec 10, 2024 |
Issue Open | Dec 11, 2024 | Dec 11, 2024 |
Issue Close | Dec 13, 2024 | Dec 13, 2024 |
Basis Of Allotment (Tentative) | Dec 16, 2024 | Dec 16, 2024 |
Initiation of Refunds (Tentative) | Dec 17, 2024 | Dec 17, 2024 |
Credit of Share (Tentative) | Dec 17, 2024 | Dec 17, 2024 |
Listing date (Tentative) | Dec 18, 2024 | Dec 18, 2024 |
Anchor Lockin End date 1 | Jan 15, 2025 | Jan 15, 2025 |
Anchor Lockin End date 2 | Mar 16, 2025 | Mar 16, 2025 |
Sai Life Sciences IPO P/E ratio is 126.42, as compared to Vishal Mega Mart IPO P/E ratio of 76.13.
Sai Life Sciences IPO | Vishal Mega Mart IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Sai Life Sciences Limited Financial Information (Restated Consolidated)Sai Life Sciences Limited's revenue increased by 20% and profit after tax (PAT) rose by 729% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Vishal Mega Mart Limited Financial Information (Restated Consolidated)Vishal Mega Mart Limited's revenue increased by 17.41% and profit after tax (PAT) rose by 43.78% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 40.48% | 96.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 35.1% | 76.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 126.42 | 76.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹11418.63 Cr. | ₹35168.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 11.79%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 15.96%% | 68.76%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.34 | ₹1.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 8.13%% | 8.18%% |
In the Sai Life Sciences IPO retail investors (RII) are offered 1,93,97,392 shares while in Vishal Mega Mart IPO retail investors are offered 1,93,97,392 shares. Qualified institutional buyers (QIB) are offered 1,10,84,225 shares in Sai Life Sciences IPO and 20,51,28,206 shares in Vishal Mega Mart IPO.
Sai Life Sciences IPO | Vishal Mega Mart IPO | |
---|---|---|
Anchor Investor Reserveration | 1,66,26,336 shares | 30,76,92,307 shares |
Market Maker Reserveration | ||
QIB | 1,10,84,225 shares | 20,51,28,206 shares |
NII | 83,13,168 shares | 15,38,46,154 shares |
RII | 1,93,97,392 shares | 35,89,74,359 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 3,87,94,785 shares | 71,79,48,719 shares |
Sai Life Sciences IPO subscribed 1.26x in total, whereas Vishal Mega Mart IPO subscribed 1.62x.
Sai Life Sciences IPO | Vishal Mega Mart IPO | |
---|---|---|
QIB (times) | 3.20x | 0.50x |
NII (times) | 0.60x | 4.05x |
Big NII (times) | 0.59x | 4.40x |
Small NII (times) | 0.63x | 3.35x |
RII (times) | 0.42x | 1.23x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.26x | 1.62x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|